Contact A Lawyer
Near You

Contact us today for a complimentary consultation with a qualified attorney near you.

More Warnings Needed for Diabetes Drug

-August 19, 2008

U.S. health regulators recently made an announcement warning about more risks found with a widely used diabetes drug.

The drug in question is Byetta, a product of Amylin Pharmaceuticals Inc.

More Risks Found with Byetta

The FDA received six more reports of hemorrhagic or necrotizing pancreatitis requiring hospitalization earlier this week.

Two of the reports involved patients who had died taking the medication.

Among the risks found with Byetta is pancreas inflammation, which appears to be the diabetes medications most common risk.

Stronger Warnings Suggested

Since these reports, the FDA says they are working on adding stronger warning labels to the drug and it is still being decided whether or not the medication will receive a “black box” warning.

Amylin says they will be more than willing to work with the FDA to update the labels and ensure patient safety.

Problems in the Past

The new reports of risks follow earlier warnings from October when the FDA found 30 reports of pancreatitis in patients using Byetta.

At the time Amylin said they would report the findings and warn patients and doctors; however, many question how much has been done since more people are encountering health problems.

(Source: Reuters)

Have you encountered health problems while taking a medication? If so, please contact us to speak with an experienced attorney who will evaluate your case and ensure you receive the legal help and guidance you need and deserve.

Contact a News Recall Lawyer